Patent · US Active

Modulation of transgene expression in plants

US11879129B2 · kind B2 · utility

1Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 12, 2022
Grant dateJan 23, 2024
Priority date
Expiry dateSep 12, 2042

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A40/146
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in seed tissues of a dicot plant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.